{"id":"CHEMBL1046","canonicalSmiles":"NCCCCCC(=O)O","inchiKey":"SLXKOJJOQWFEFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOCAPROIC ACID","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amicar","Aminocaproic","Aminocaproic acid","Epsikapron"],"synonyms":[".epsilon.-aminocaproic acid","177 J.D","177 J.D.","177 JD","177-JD","6-aminocaproic acid","Aminocaproic acid","CL 10304","CL-10304","CY-116","EACA","Epsilcapramin","Epsilon-aminocaproic acid","Hexanoic acid, 6-amino-","NSC-26154","NSC-400230"],"crossReferences":{"DailyMed":["aminocaproic%20acid"],"PubChem":["11110778","11110779","144203632","170465057","174007004","26747439","26747440","50105811","50105812","57260392","85230919","90341441"],"Wikipedia":["Aminocaproic_acid"],"drugbank":["DB00513"],"chEBI":["16586"]},"linkedTargets":{"rows":["ENSG00000122194","ENSG00000104368"],"count":2},"linkedDiseases":{"rows":["MP_0001914","MP_0001845","EFO_1000760","EFO_0005775","EFO_0004273","Orphanet_1531","EFO_0005669","EFO_0003843","MONDO_0005178"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for hemorrhage and has 4 investigational indications."}
{"id":"CHEMBL1070","canonicalSmiles":"COc1ccc2cc(CCC(C)=O)ccc2c1","inchiKey":"BLXXJMDCKKHMKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NABUMETONE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nabumetone","Relafen","Relifex"],"synonyms":["BRL 14777","BRL-14777","NSC-758623","Nabumetone"],"crossReferences":{"DailyMed":["nabumetone"],"PubChem":["11112767","124882597","144204198","170464970","26748824","8139968"],"Wikipedia":["Nabumetone"],"drugbank":["DB00461"],"chEBI":["7443"]},"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0004616","MONDO_0005178","EFO_0005755"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 3 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1142","canonicalSmiles":"Nc1ccc(O)cc1","inchiKey":"PLIKAWJENQZMHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-AMINOPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P-Aminophenol"],"crossReferences":{"PubChem":["124890037","144206793","144207026","144208228","170466875","17388802","47193681"],"Wikipedia":["4-Aminophenol"],"drugbank":["DB14144"],"chEBI":["17602"]},"childChemblIds":["CHEMBL388353"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1162144","canonicalSmiles":"CC(=O)C(=O)O","inchiKey":"LCTONWCANYUPML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRUVATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxopropanoate","Pyruvate"],"crossReferences":{"PubChem":["144209294","144213601"],"Wikipedia":["Pyruvic_acid"],"drugbank":["DB00119"],"chEBI":["32816"]},"childChemblIds":["CHEMBL181886"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1200440","canonicalSmiles":"Cc1cccc(C)c1NC(=O)C1CCCCN1C.Cl","inchiKey":"RETIMRUQNCDCQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPIVACAINE HYDROCHLORIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1087","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arestocaine hydrochloride","Carbocaine","Isocaine hydrochloride","Mepivacaine hydrochloride","Polocaine","Polocaine-mpf","Scandicaine","Scandonest","Scandonest plain"],"synonyms":["Mepivacaine hcl","Mepivacaine hydrochloride","Mepivacaine monohydrochloride","NSC-758674","Optocain","Scandicain"],"crossReferences":{"DailyMed":["mepivacaine%20hydrochloride"],"PubChem":["144204977","26748921","56424124"],"chEBI":["6760"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1200865","canonicalSmiles":"CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"DMKSVUSAATWOCU-HROMYWEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOTEPREDNOL ETABONATE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Airex","Alrex","Eysuvis","Inveltys","Lotemax","Lotemax sm"],"synonyms":["CDDD 5604","CDDD-5604","HGP-1","KPI-121","Loteprednol","Loteprednol etabonate","P-5604"],"crossReferences":{"DailyMed":["loteprednol%20etabonate"],"PubChem":["144205772","170465195","26758016"],"drugbank":["DB14596"],"chEBI":["31784"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0007957","MP_0001845","EFO_1000811","HP_0200026","EFO_1000879","EFO_1000906","MONDO_0005129","EFO_0009536","EFO_0007363","EFO_0007141","MONDO_0004768","EFO_0005752","EFO_0009450"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 5 approved and 3 investigational indications."}
{"id":"CHEMBL1200952","canonicalSmiles":"CN[C@@H](C)Cc1ccccc1.Cl","inchiKey":"TWXDDNPPQUTEOV-FVGYRXGTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHAMPHETAMINE HYDROCHLORIDE","yearOfFirstApproval":1943,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201201","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Desoxyn","Methampex","Methamphetamine hydrochloride"],"synonyms":["Desoxyephedrine hydrochloride","Metamfetamine hydrochloride","Methamphetamine hcl","Methamphetamine hydrochloride","Methamphetamine hydrochloride cii","Methylamfetamine hydrochloride","NSC-169505"],"crossReferences":{"DailyMed":["methamphetamine%20hydrochloride"],"PubChem":["144206409"],"chEBI":["35340"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0004701"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1943 and is indicated for attention deficit hyperactivity disorder. It was withdrawn in United States. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201116","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](N3C(=O)[C@@H](c4ccccc4)NC3(C)C)C(=O)N2[C@H]1C(=O)O","inchiKey":"DXVUYOAEDJXBPY-NFFDBFGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HETACILLIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hetacin","Natacillin","Versapen"],"synonyms":["BL-P 804","BL-P-804","BLP-804","BRL-804","Hetacillin","Hetacillin acid"],"crossReferences":{"Wikipedia":["Hetacillin"],"drugbank":["DB00739"],"chEBI":["5683"]},"childChemblIds":["CHEMBL1201121"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for bacterial disease."}
{"id":"CHEMBL1201125","canonicalSmiles":"CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"VLHUSFYMPUDOEL-WZTVWXICSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IOTHALAMATE MEGLUMINE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201300","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Conray","Conray 30","Conray 43","Cysto-conray ii"],"synonyms":["Iotalamate meglumine","Iothalamate meglumine","Meglumine iotalamate","Meglumine iotalamate injection","Meglumine iothalamate"],"crossReferences":{"DailyMed":["iothalamate%20meglumine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201575","drugType":"Antibody","blackBoxWarning":false,"name":"EFALIZUMAB","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Neurotoxicity"],"year":2009},"tradeNames":["Raptiva"],"synonyms":["ANTI-CD11A","Efalizumab","HU-1124","HU1124"],"crossReferences":{"DrugCentral":["4959"],"Wikipedia":["Efalizumab"]},"linkedTargets":{"rows":["ENSG00000005844"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_1000710","EFO_0001365","MONDO_0005147","MONDO_0004670","EFO_0003884","EFO_0000676","Orphanet_700","EFO_0003778","EFO_0000274","EFO_0000540","EFO_0009321","EFO_0000699"],"count":13},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for immune system disease and has 10 investigational indications. It was withdrawn in United States  in 2009 due to Neurotoxicity."}
{"id":"CHEMBL1201638","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP PROTAMINE ZINC PURIFIED PORK","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Protamine zinc and iletin ii (pork)"],"synonyms":["Insulin susp protamine zinc purified pork"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1979."}
{"id":"CHEMBL12279","canonicalSmiles":"Cc1cc(=O)oc2ccccc12","inchiKey":"PSGQCCSGKGJLRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL12279","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08785"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230122","canonicalSmiles":"Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21","inchiKey":"KKKRKRMVJRHDMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-1487","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103905625","174007011"],"drugbank":["DB06518"]},"childChemblIds":["CHEMBL1766582"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233976","canonicalSmiles":"N[C@@H](CCCCO)C(=O)O","inchiKey":"OLUWXTFAPJJWPL-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233976","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4252661"],"drugbank":["DB03412"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234009","canonicalSmiles":"c1ccc2c(c1)Cc1c-2n[nH]c1-c1ccncc1","inchiKey":"NHOACLCXCKJMAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03490"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234200","canonicalSmiles":"CS(=O)(=O)c1cccc(-c2cc(N3CC[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)c1","inchiKey":"GOBIXGZJSMAOFV-QRWLVFNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234200","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08164"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235482","canonicalSmiles":"O=CCCCC=O","inchiKey":"SXRSQZLOMIGNAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTARAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sonacide"],"synonyms":["Glutaral","Glutaral concentrate","Glutaraldehyde","Glutaric acid dialdehyde","NSC-13392","Sterihyde l"],"crossReferences":{"PubChem":["144204634","144208940","144213612","17388988"],"drugbank":["DB03266"],"chEBI":["64276"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235872","canonicalSmiles":"O=S(=O)(O)OC[C@H]1O[C@H](O[C@]2(COS(=O)(=O)O)O[C@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]2OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O","inchiKey":"WEPNHBQBLCNOBB-UGDNZRGBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCROSOFATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sucrose octasulfate","Sucrosofate"],"crossReferences":{"drugbank":["DB01901"]},"childChemblIds":["CHEMBL3989532"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237122","canonicalSmiles":"CCCCC[C@](C)(O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)O","inchiKey":"DLJKPYFALUEJCK-IIELGFQLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CARBOPROST","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hemabate"],"synonyms":["(15s)-15-methyl-pgf2.alpha.","15-methyl-pgf2.alpha.","15-methylprostaglandin f2.alpha.","Carboprost","U-32,921","U-32921"],"crossReferences":{"DailyMed":["carboprost%20tromethamine"]},"childChemblIds":["CHEMBL1237105"],"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0009579"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for postpartum hemorrhage and hemorrhage. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1241239","canonicalSmiles":"C/C=C/[C@H]1O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]2OC)C[C@@H](O[C@H]2C[C@@H](O)[C@H](OC(N)=O)[C@@H](C)O2)[C@@H]1C","inchiKey":"DJZCTUVALDDONK-HQMSUKCRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CONCANAMYCIN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14062"],"chEBI":["73167"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256","canonicalSmiles":"FC(F)OC(Cl)C(F)(F)F","inchiKey":"PIWKPBJCKXDKJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOFLURANE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerrane","Forane","Isoflurane"],"synonyms":["COMPOUND 469","COMPOUND-469","Isoflurane"],"crossReferences":{"DailyMed":["isoflurane"],"PubChem":["144206238","144208029","50125772"],"Wikipedia":["Isoflurane"],"drugbank":["DB00753"],"chEBI":["6015"]},"linkedTargets":{"rows":["ENSG00000169427","ENSG00000109158","ENSG00000145863","ENSG00000082482","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000102287","ENSG00000182256","ENSG00000186795","ENSG00000171303","ENSG00000100433","ENSG00000094755","ENSG00000268089","ENSG00000145888","ENSG00000113327","ENSG00000163285","ENSG00000186297","ENSG00000163288"],"count":22},"linkedDiseases":{"rows":["EFO_0009686","EFO_0003869","EFO_0003777","EFO_0011061","EFO_0006834","EFO_0002687","EFO_0001645","EFO_0009267","EFO_1002048","EFO_0000713","MONDO_0100096","EFO_1001801","EFO_0005611","HP_0000023","EFO_0005251"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 5 investigational indications."}
{"id":"CHEMBL1274","canonicalSmiles":"CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O","inchiKey":"XWXYUMMDTVBTOU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NILUTAMIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anadron","Nilandron","Nilutamide"],"synonyms":["NSC-758683","Nilutamide","RU 23908","RU-23908"],"crossReferences":{"DailyMed":["nilutamide"],"PubChem":["104171203","11111555","11111556","11114201","124880925","124880926","144203764","144211906","170465021","174007285","26747174","26747175","26752242","50104947","50104948","50104949","50104950","56463082","85231160","90341288"],"Wikipedia":["Nilutamide"],"drugbank":["DB00665"],"chEBI":["7573"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000673","EFO_0000196","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1323","canonicalSmiles":"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1","inchiKey":"CJBJHOAVZSMMDJ-HEXNFIEUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARUNAVIR","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prezista"],"synonyms":["Darunavir","MC-114","TMC 114","TMC-114","TMC-41629","TMC114","UIC-94017","UIC-940T"],"crossReferences":{"DailyMed":["darunavir"],"PubChem":["144206187"],"Wikipedia":["Darunavir"],"drugbank":["DB01264"],"chEBI":["367163"]},"childChemblIds":["CHEMBL1201127"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 5 approved and 9 investigational indications."}
{"id":"CHEMBL1358","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"VWUXBMIQPBEWFH-WCCTWKNTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FULVESTRANT","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Faslodex"],"synonyms":["Faslodex","Fulvestrant","ICI 182,780","ICI-182780","NSC-759879","ZD-9238","ZD9238"],"crossReferences":{"DailyMed":["fulvestrant"],"PubChem":["144204490","144209802","144213958","170464917","90341164"],"Wikipedia":["Fulvestrant"],"drugbank":["DB00947"],"chEBI":["31638"]},"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0005232","EFO_0003869","EFO_0001361","EFO_0003859","MONDO_0007254","EFO_0005952","EFO_0000305","EFO_1001951","EFO_0000588","EFO_0002690","EFO_1001331","MONDO_0008903","EFO_0000673","EFO_0008528","EFO_1000919","EFO_0000616","EFO_0002618","Orphanet_145","EFO_0000186","EFO_0006318","Orphanet_562","MONDO_0008170","EFO_1001512","EFO_0000313","MONDO_0004379","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0009708","EFO_0000553","MONDO_0011962","EFO_0000702","EFO_0000574","EFO_0000432","MONDO_0024880","EFO_0000181"],"count":36},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 5 approved and 25 investigational indications."}
{"id":"CHEMBL1490434","canonicalSmiles":"N=C(N)/N=C(\\N)N1CCOCC1","inchiKey":"KJHOZAZQWVKILO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOROXYDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABOB","Moroxydine","SKF 8898-A","SKF-8898-A","SKF-8898A"],"crossReferences":{"PubChem":["11112529","11112530","174006214"],"drugbank":["DB13597"]},"childChemblIds":["CHEMBL1874337"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1532","canonicalSmiles":"CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1","inchiKey":"AGMMTXLNIQSRCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINETHAZONE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hydromox"],"synonyms":["Chinethazone","NSC-759904","Quinethazone"],"crossReferences":{"PubChem":["144203917","170465167","56463176"],"Wikipedia":["Quinethazone"],"drugbank":["DB01325"],"chEBI":["8717"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1963 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1624075","canonicalSmiles":"CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1","inchiKey":"QDYLMAYUEZBUFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETALKONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetalkonium cation","Cetalkonium ion"],"crossReferences":{"drugbank":["DB11583"]},"childChemblIds":["CHEMBL1553978","CHEMBL1644450","CHEMBL2414246"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1651956","canonicalSmiles":"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C","inchiKey":"OLROWHGDTNFZBH-XEMWPYQTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ALISPORIVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(d-meala)3-(etval)4-csa","Alisporivir","DEB 025","DEB-025","DEB025","DEBIO 025","DEBIO-025","Debio 025","UNIL 025","UNIL-025"],"crossReferences":{"Wikipedia":["Alisporivir"],"drugbank":["DB12139"]},"linkedTargets":{"rows":["ENSG00000196262"],"count":1},"linkedDiseases":{"rows":["EFO_0004220","MONDO_0100096","EFO_0001421","EFO_0003884","EFO_0003047"],"count":5},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1683590","canonicalSmiles":"C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@H]3[C@H](C[C@H]4O[C@@H](CC[C@@H]1O2)C[C@@H](C)C4=C)O[C@H](C[C@H](O)CN)[C@@H]3OC","inchiKey":"UFNVPOGXISZXJD-JBQZKEIOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERIBULIN","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Halaven"],"synonyms":["ER-086526","Eribulin"],"crossReferences":{"DailyMed":["eribulin%20mesylate"],"drugbank":["DB08871"],"chEBI":["63587"]},"childChemblIds":["CHEMBL1683544","CHEMBL3526882"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000637","EFO_0001075","MONDO_0015686","MONDO_0004192","EFO_0000681","MONDO_0007254","EFO_0000305","EFO_1000984","MONDO_0001187","EFO_1000044","EFO_0003968","MONDO_0002974","EFO_0000389","EFO_1000251","EFO_0000673","EFO_0008528","EFO_0002617","EFO_0000616","Orphanet_145","EFO_0006859","MONDO_0015523","MONDO_0004669","EFO_1001968","MONDO_0016238","EFO_0003060","MONDO_0008315","EFO_0000311","MONDO_0021632","EFO_0000304","EFO_0006861","EFO_0005537","EFO_0000574","EFO_0006544","MONDO_0024880","EFO_0000691"],"count":36},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 5 approved and 30 investigational indications."}
{"id":"CHEMBL1742455","canonicalSmiles":"CN1C(=O)[C@@H](NC(=O)c2cc3cccc4c3n2CCC4)N=C(c2ccccc2)c2ccccc21","inchiKey":"CZPILLBHPRAPCB-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARAZEPIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tarazepide"],"crossReferences":{"drugbank":["DB06435"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1770916","canonicalSmiles":"CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1","inchiKey":"VFCRKLWBYMDAED-REWPJTCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIROGACESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nirogacestat","PF 03084014","PF 3084014","PF-03084014","PF-3084014"],"crossReferences":{"drugbank":["DB12005"]},"childChemblIds":["CHEMBL4298153"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1879463","canonicalSmiles":"Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21","inchiKey":"JOGKUKXHTYWRGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DACTOLISIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BEZ-235","BEZ235","Bez-235","Dactolisib","NSC-751249","NVP-BEZ235","NVP-BEZ235-NX","Nvp-bez-235","RTB-101","RTB101","Rtb101"],"crossReferences":{"PubChem":["103905146","124898663","124898665","99460876"],"drugbank":["DB11651"],"chEBI":["71952"]},"childChemblIds":["CHEMBL3039506","CHEMBL1911126"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000601","MONDO_0100096","EFO_0000544","MONDO_0011962","MONDO_0007254","MONDO_0002367","MONDO_0008315","EFO_1000045","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1889436","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O.O.O.O.O.O.O.O.O","inchiKey":"TYBARJRCFHUHSN-DMJRSANLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OUABAIN","maximumClinicalTrialPhase":4,"parentId":"CHEMBL222863","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ouabaine arnaud","Strodival"],"synonyms":["Acocantherin","Acocantherin octahydrate","G-strophanthin","Gratus strophanthin","NSC-25485","NSC-757425","Ouabain","Ouabain anhydrous","Ouabain octahydrate","Purostrophan","Strophantin-g","Strophoperm"],"crossReferences":{"PubChem":["124883190","26753628"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL1908847","canonicalSmiles":"C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1","inchiKey":"SLRCCWJSBJZJBV-ZQDZILKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1908847","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144203937","170465740"],"drugbank":["DB06727"],"chEBI":["28827"]},"childChemblIds":["CHEMBL3276452","CHEMBL2165222"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1909288","canonicalSmiles":"CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)C(=O)N(C(C)=O)c3ccccc32)cc1","inchiKey":"JPGUEMQIAGJQSJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIACETYLDIPHENOLISATIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Australia"],"classes":["Hepatotoxicity"],"year":1971},"tradeNames":[],"synonyms":["Phenisatin","Triacetyldiphenolisatin","Trisatin"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Australia  in 1971 due to Hepatotoxicity."}
{"id":"CHEMBL1938400","canonicalSmiles":"CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(-c4ccccc4SCCO)n3c2)n(-c2ccc(O)c(Cl)c2)n1","inchiKey":"VGEXRDWWPSGZDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03715455","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-03715455","Pf-03715455"],"crossReferences":{"drugbank":["DB12138"]},"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1963684","drugType":"Protein","blackBoxWarning":true,"name":"PEGINESATIDE ACETATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omontys","Omontys preservative free"],"synonyms":["AF37702","Hematide acetate","Peginesatide acetate"],"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_0004272"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for anemia (phenotype). This drug has a black box warning from the FDA."}
{"id":"CHEMBL197277","canonicalSmiles":"O=S(=O)(Nc1cccc(Oc2ccc(F)cc2)c1)N1CCC(NCc2ccccc2O)CC1","inchiKey":"JHHBGNIRSUTQAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL197277","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04632"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1973733","canonicalSmiles":"O=C(O)CN(CC(=O)O)Cc1cc2c(cc1O)Oc1cc(O)c(CN(CC(=O)O)CC(=O)O)cc1C21OC(=O)c2ccccc21","inchiKey":"DEGAKNSWVGKMLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OFTASCEINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcein","Fluorescein complexon","Fluorexon","NSC-298193","Oftasceine"],"crossReferences":{"PubChem":["147488"],"drugbank":["DB11184"],"chEBI":["51903"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1997663","canonicalSmiles":"CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN(CC)CC)c1ccccc1S2","inchiKey":"PQXGNJKJMFUPPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHACIZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EZ-55","Etacizin","Ethacizin","Ethacizine","Ethacyzin","Etmozine daa","NIK-244","NSC-621878"],"crossReferences":{"PubChem":["490383"],"drugbank":["DB13645"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2035460","canonicalSmiles":"O=c1c2ccccc2[se]n1CCn1[se]c2ccccc2c1=O","inchiKey":"SFFSGPCYJCMDJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHASELEN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bbske","Compound eb","Ethaselen","Ethaselen-1","Shuang-xi-zuo-wan-1"],"crossReferences":{"drugbank":["DB15051"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2062276","canonicalSmiles":"C=CCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13.O=C(O)C(O)C(O)C(=O)O","inchiKey":"FWMLYVACGDQRFU-MBHUSPCXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVALLORPHAN TARTRATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1254682","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lorfan"],"synonyms":["Levallorphan tartrate","Naloxiphane tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL2105732","canonicalSmiles":"CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN.Cl","inchiKey":"XNCDYJFPRPDERF-NQQJLSKUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVOMILNACIPRAN HYDROCHLORIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL99946","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fetzima"],"synonyms":["F 2695 HYDROCHLORIDE","F-2695 HYDROCHLORIDE","F2695","F2695 HYDROCHLORIDE","Levomilnacipran hydrochloride"],"crossReferences":{"DailyMed":["levomilnacipran%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0005687","HP_0002140","MONDO_0002009","EFO_0003761"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108144","drugType":"Antibody","blackBoxWarning":false,"name":"TENELIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-224819","Teneliximab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108324","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"OBLIMERSEN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oblimersen"],"crossReferences":{"DrugCentral":["4792"]},"linkedTargets":{"rows":["ENSG00000171791"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108555","drugType":"Unknown","blackBoxWarning":false,"name":"PETROLATUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Petrolatum","Petroleum jelly","Yellow petrolatum"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109300","drugType":"Antibody","blackBoxWarning":false,"name":"GSK933776","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK933776","Gsk933776"],"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["EFO_1001492","MONDO_0004975"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2110603","canonicalSmiles":"CNCC12CCC(c3ccccc31)c1ccccc12","inchiKey":"GNRXCIONJWKSEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOCTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzoctamine"],"crossReferences":{"drugbank":["DB09021"]},"childChemblIds":["CHEMBL2104106"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2115116","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C","inchiKey":"OHYGPBKGZGRQKT-XGQKBEPLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECLOMETHASONE 17-MONOPROPIONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["17-bmp","Beclomethasone 17-monopropionate","Beclomethasone 17-propionate","Beclomethasone-17-monopropionate"],"crossReferences":{"drugbank":["DB14221"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146125","canonicalSmiles":"[MgH2]","inchiKey":"RSHAOIXHUHAZPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Magnesium"],"crossReferences":{"drugbank":["DB14513"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL219695","canonicalSmiles":"O=C(O)CCCNC(=O)NC1CCCCC1","inchiKey":"WSVFRGGLURJIMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-(3-Cyclohexylureido)Butanoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(3-Cyclohexylureido)Butanoic Acid"],"crossReferences":{"drugbank":["DB08257"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL223448","canonicalSmiles":"Oc1c(Br)cc(Br)c2cccnc12","inchiKey":"ZDASUJMDVPTNTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROXYQUINOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Broxyquinoline","Dibromohydroxyquinoline","NSC-1810","Starogyn"],"crossReferences":{"PubChem":["144204891","170466167","26748318","93576738"],"drugbank":["DB13536"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364649","drugType":"Antibody","blackBoxWarning":true,"name":"MARGETUXIMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Margenza"],"synonyms":["MGAH-22","MGAH22","Margetuximab","Margetuximab-cmkb"],"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for breast cancer. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2365665","canonicalSmiles":"CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"GJKXGJCSJWBJEZ-XRSSZCMZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DESLORELIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Somagard [as acetate]"],"synonyms":["D-TRP LHRH-PEA","D-TRP-LHRH-PEA","Deslorelin"],"crossReferences":{"drugbank":["DB11510"]},"childChemblIds":["CHEMBL2357192"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL238465","canonicalSmiles":"Clc1cc(N2C[C@@H]3CN[C@@H]3C2)cnc1Cl","inchiKey":"MBQYQLWSBRANKQ-IMTBSYHQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOFINICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-422894.0","ABT-894","Sofinicline"],"crossReferences":{"drugbank":["DB12527"]},"childChemblIds":["CHEMBL2105654"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003888","MONDO_0001583","EFO_0000401"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL245019","canonicalSmiles":"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O","inchiKey":"HZQDCMWJEBCWBR-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIZORIBINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bredinin","Mizoribine","NSC-289637"],"crossReferences":{"PubChem":["11532986","170466027","50106568","50106569","90340602"],"drugbank":["DB12617"]},"linkedTargets":{"rows":["ENSG00000163655","ENSG00000106348","ENSG00000178035"],"count":3},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005761","EFO_0004255"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL270512","canonicalSmiles":"O=c1c2c(O)cccc2oc2c([N+](=O)[O-])ccc(O)c12","inchiKey":"ZOHCDJRFYXKEQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL270512","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02170"],"chEBI":["77321"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL281812","canonicalSmiles":"NC(=O)c1cc(N(CCCl)CCCl)c([N+](=O)[O-])cc1[N+](=O)[O-]","inchiKey":"DQMALWRRERBILB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SN-23862","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SN-23862"],"crossReferences":{"drugbank":["DB03228"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL295124","canonicalSmiles":"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2","inchiKey":"YBHILYKTIRIUTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BERBERINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Berbericine","Berberin","Berberine","Berberone","Majarine","Thalsine","Umbellatin","Umbellatine"],"crossReferences":{"PubChem":["104171310","11112431","124882365","26753128"],"drugbank":["DB04115"],"chEBI":["16118"]},"childChemblIds":["CHEMBL1985435","CHEMBL492613","CHEMBL12089"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3039519","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc(-c3csc4c(-c5ccc(-c6c[nH]c([C@@H]7CCCN7C(=O)[C@H](NC(=O)OC)c7ccccc7)n6)cc5)csc34)ccc2[nH]1)C(C)C","inchiKey":"ATOLIHZIXHZSBA-BTSKBWHGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMATASVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDX-18719","IDX18719","Samatasvir"],"crossReferences":{"drugbank":["DB12660"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3040440","canonicalSmiles":"CNC(=O)c1ccccc1Nc1cc(Nc2ccc(N3CCOCC3)cc2OC)ncc1C(F)(F)F","inchiKey":"IGUBBWJDMLCRIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VS-4718","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VS-4718"],"crossReferences":{"drugbank":["DB15273"]},"childChemblIds":["CHEMBL2430358"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137309","canonicalSmiles":"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1","inchiKey":"LQBVNQSMGBZMKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VENETOCLAX","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Venclexta"],"synonyms":["ABT-199","GDC-0199","RG-7601","RG7601","Venetoclax"],"crossReferences":{"DailyMed":["venetoclax"],"drugbank":["DB11581"]},"linkedTargets":{"rows":["ENSG00000171791"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003869","MONDO_0000873","EFO_0002913","MONDO_0007254","EFO_1000131","EFO_1001469","EFO_0005952","EFO_0000209","MONDO_0003541","Orphanet_85443","EFO_0000565","EFO_0000309","EFO_0004251","EFO_0000339","EFO_0000096","MONDO_0019460","EFO_0004289","EFO_0000196","EFO_0002427","MONDO_0020743","EFO_0000094","EFO_0010580","MONDO_0002083","EFO_0000198","EFO_0000616","EFO_0009441","EFO_0000220","MONDO_0019457","MONDO_0004670","EFO_0000403","EFO_0000222","MONDO_0000870","MONDO_0017596","MONDO_0044881","EFO_0003060","EFO_0000311","EFO_1001934","MONDO_0044889","EFO_0003032","MONDO_0001023","EFO_0000095","MONDO_0044917","EFO_0000702","EFO_0000574","EFO_1000560","EFO_0001378","MONDO_0018906"],"count":48},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 3 approved and 32 investigational indications."}
{"id":"CHEMBL3137343","drugType":"Antibody","blackBoxWarning":false,"name":"PEMBROLIZUMAB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Keytruda"],"synonyms":["KEYLYNK-010 COMPONENT PEMBROLIZUMAB","Lambrolizumab","MK-3475","PEMBROLIZUMAB COMPONENT OF KEYLYNK-010","Pembrolizumab","SCH-900475"],"crossReferences":{"DailyMed":["pembrolizumab"],"DrugCentral":["4924"]},"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_1000256","EFO_0003891","EFO_0000637","EFO_0000365","EFO_0000558","EFO_0000756","EFO_0000681","EFO_0005952","MONDO_0044704","EFO_1000431","EFO_1000984","EFO_1001951","MONDO_0000548","EFO_0000588","EFO_0000096","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0008528","EFO_1000532","MONDO_0015277","MONDO_0003659","Orphanet_2495","EFO_0000760","MONDO_0002038","MONDO_0018352","MONDO_0021054","EFO_0000198","EFO_0002618","EFO_1000465","EFO_1001931","MONDO_0002715","EFO_0005922","MONDO_0019465","EFO_0001642","EFO_1001973","EFO_1001512","MONDO_0002363","EFO_1001968","MONDO_0044915","MONDO_0004986","MONDO_0008315","EFO_0005221","MONDO_0001879","EFO_1000489","MONDO_0044889","MONDO_0000544","EFO_0009259","MONDO_0019472","EFO_0004284","EFO_0000574","MONDO_0044925","EFO_0001378","EFO_1000796","MONDO_0018079","EFO_0003073","MONDO_0002928","MONDO_0021117","EFO_0002913","EFO_1001465","MONDO_0007254","EFO_1001012","EFO_0004252","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_0003968","MONDO_0002898","MONDO_0017387","EFO_0004289","MONDO_0024474","EFO_0000196","EFO_0000326","EFO_0002499","EFO_0000183","EFO_0000707","MONDO_0002083","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","Orphanet_59305","MONDO_0019457","MONDO_0024503","EFO_0000403","Orphanet_44890","MONDO_0005341","EFO_0000222","MONDO_0000521","MONDO_0007576","EFO_0004198","MONDO_0043243","EFO_1001471","EFO_0000304","MONDO_0002120","MONDO_0021148","EFO_0002517","EFO_1000499","MONDO_0011962","EFO_0000702","EFO_0000764","MONDO_0002367","MONDO_0018906","MONDO_0024880","EFO_1001927","EFO_0000519","EFO_0005232","MONDO_0003060","EFO_0003869","HP_0002745","EFO_0001075","EFO_1000592","MONDO_0003890","EFO_0000571","EFO_1000261","EFO_1000657","EFO_0000228","EFO_0000565","MONDO_0003660","EFO_0009709","EFO_0000389","EFO_0000182","MONDO_0005411","MONDO_0003199","MONDO_0018531","EFO_0007541","EFO_1000785","EFO_0000094","EFO_0002921","EFO_0001416","EFO_0009441","EFO_1000595","Orphanet_145","EFO_0003893","MONDO_0004658","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_0003017","EFO_0005842","MONDO_0044881","EFO_0007143","EFO_0009708","EFO_0000294","EFO_1000576","EFO_0001061","MONDO_0100096","EFO_0003868","EFO_1001100","EFO_0003851","EFO_0005537","EFO_0000432","EFO_1001051","EFO_0006544","EFO_1000613","EFO_0000563","EFO_1000624","MONDO_0009348","MONDO_0100342","MONDO_0015686","EFO_1001901","MONDO_0044887","EFO_0004230","EFO_0005950","EFO_1001469","MONDO_0021063","MONDO_0002087","EFO_0000305","MONDO_0020657","EFO_0000231","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_0003860","EFO_0006352","EFO_0000770","MONDO_0001657","EFO_0000673","EFO_0002626","EFO_0000717","EFO_0002617","MONDO_0000430","EFO_1000616","EFO_0000503","MONDO_0044785","EFO_0000478","EFO_0000313","EFO_0004243","EFO_0003060","MONDO_0003865","EFO_0000621","EFO_0000311","EFO_0000640","EFO_0003863","MONDO_0002529","EFO_1000581","EFO_0006861","EFO_0000095","EFO_0002892","EFO_0004142","MONDO_0003219","EFO_0003833","EFO_0000691","EFO_0000181","MONDO_0004700","EFO_1000233"],"count":207},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 5 approved and 153 investigational indications."}
{"id":"CHEMBL316561","canonicalSmiles":"CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1","inchiKey":"DGMKFQYCZXERLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROGLUMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Respiratory toxicity"],"year":1989},"tradeNames":["Milid","Nulsa"],"synonyms":["Binoside","CR-242","Dl-proglumide","Gastrotopic","Midelid","NSC-757841","Proglumide","Promid","Ulcutin","W-5219","Xylamide"],"crossReferences":{"PubChem":["144204108","170465774","26747589","50106676","56463359","90341320"],"Wikipedia":["Proglumide"],"drugbank":["DB13431"],"chEBI":["32058"]},"childChemblIds":["CHEMBL1345380"],"linkedTargets":{"rows":["ENSG00000110148","ENSG00000163394"],"count":2},"linkedDiseases":{"rows":["HP_0004398","EFO_0001422","EFO_0003948","EFO_1001249"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for peptic ulcer and gastroesophageal reflux disease and has 2 investigational indications. It was withdrawn in Germany  in 1989 due to Respiratory toxicity."}
{"id":"CHEMBL3182071","canonicalSmiles":"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)[C@@H]1OC","inchiKey":"SZLZWPPUNLXJEA-LAFLMMDJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3182071","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204162"],"drugbank":["DB01180"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3265032","canonicalSmiles":"c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1","inchiKey":"XSMSNFMDVXXHGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENTOSPLETINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Entospletinib","GS-9973","SYK INHIBITOR GS-9973"],"crossReferences":{"drugbank":["DB12121"]},"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["EFO_0000220","EFO_0000095","EFO_0000403","EFO_0000222","MONDO_0018906","EFO_1001469","EFO_0005952","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3301621","canonicalSmiles":"c1ccc2cc([C@]34CNC[C@H]3C4)ccc2c1","inchiKey":"HKHCSWPSUSWGLI-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENTANAFADINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Centanafadine","DOV 216,419","DOV 216,419 free base","DOV-216419","EB-1020","EB-1020 free base"],"crossReferences":{"drugbank":["DB14841"]},"childChemblIds":["CHEMBL3301615"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005203","EFO_0004319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL331282","canonicalSmiles":"NCCCCNC(=O)c1ccc(S(N)(=O)=O)cc1","inchiKey":"ZDYFRIZTYRFPJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL331282","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03697"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL346331","canonicalSmiles":"CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1","inchiKey":"WCJFBSYALHQBSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORMETHADONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eucopon","HOECHST 10582","HOECHST-10582","IDS-NN-007","Isomethadone i","J5.915C","Mepidon","NSC-19598","Normethadone","Phenyldimazone"],"crossReferences":{"PubChem":["170465674"],"Wikipedia":["Normethadone"],"drugbank":["DB11609"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544960","canonicalSmiles":"NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1","inchiKey":"IIRWNGPLJQXWFJ-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AT-13148","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT13148","At-13148"],"linkedTargets":{"rows":["ENSG00000162889","ENSG00000134318","ENSG00000067900"],"count":3},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545091","drugType":"Small molecule","blackBoxWarning":false,"name":"XEN403","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xen403"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545232","canonicalSmiles":"Cc1ccc(-c2ccc(OC3CN4CCC3CC4)cn2)cc1","inchiKey":"NPDLTEZXGWRMLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AQW051","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aqw051"],"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","HP_0100543","MONDO_0004975"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545357","drugType":"Small molecule","blackBoxWarning":false,"name":"JTE-151","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jte-151"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3559671","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYVINYL ALCOHOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hypotears","Hypotears pf","Liquifilm","Liquifilm tears","Polyalc","Sno tears"],"synonyms":["E-1203","Ethenol, homopolymer","Hydrolysed polyvinyl acetate","Hydrolyzed polyvinyl acetate","Ins-1203","Polyvinyl alcohol","Polyvinyl alcohol, unspecified"],"crossReferences":{"DrugCentral":["4279"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for fatigue."}
{"id":"CHEMBL3647536","canonicalSmiles":"CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21","inchiKey":"PTTQXDBPTFOCMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARIGABAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CVL-865","Cvl-865","Darigabat","PF-06372865","Pf-06372865"],"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000182256","ENSG00000102287","ENSG00000022355","ENSG00000094755","ENSG00000268089","ENSG00000113327","ENSG00000163285","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_1001892","EFO_0004262","HP_0003419","HP_0001250","EFO_1001146"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL36591","canonicalSmiles":"CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1","inchiKey":"FZSPJBYOKQPKCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALAPROCLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alaproclate","GEA 654","GEA-654","NSC-758657"],"crossReferences":{"PubChem":["104171098","144203617","170466583","26748907","90341341"],"Wikipedia":["Alaproclate"],"drugbank":["DB13233"]},"childChemblIds":["CHEMBL1256359"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707358","drugType":"Enzyme","blackBoxWarning":false,"name":"OLIPUDASE ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GZ-402665","GZ402665","Olipudase alfa","RHASM"],"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL378160","canonicalSmiles":"O=S(=O)(Nc1cc(-c2cccs2)nn1-c1ccc(F)cc1)c1cccc(F)c1","inchiKey":"GULUFDCOGAXLEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL378160","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08560"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833307","drugType":"Antibody","blackBoxWarning":false,"name":"SATRALIZUMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enspryng"],"synonyms":["RG6168","SA-237","SA237","Sapelizumab","Satralizumab","Satralizumab-mwge"],"linkedTargets":{"rows":["ENSG00000160712","ENSG00000134352"],"count":2},"linkedDiseases":{"rows":["EFO_0004256","EFO_0004991","EFO_0000540"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for immune system disease and neuromyelitis optica and has 1 investigational indication."}
{"id":"CHEMBL3904602","canonicalSmiles":"CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1","inchiKey":"YPJRHEKCFKOVRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEROCICLIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G1T38","G1T38 FREE BASE","G1t38","Lerociclib"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3946483","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCN)NC(=O)[C@@H](CCN)NC(=O)[C@H](CCCN)NC(=O)[C@H](CCN)NC1=O","inchiKey":"RIDRXGOBXZLKHZ-NZUANIILSA-N","drugType":"Protein","blackBoxWarning":false,"name":"MUREPAVADIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Murepavadin","POL-7080","POL7080","Pol7080","RO-7033877","RO7033877","Ro7033877"],"crossReferences":{"drugbank":["DB14777"]},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989944","canonicalSmiles":"COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O","inchiKey":"YIMYDTCOUQIDMT-SNAWJCMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIROXIMEL FUMARATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vumerity"],"synonyms":["ALKS 8700","ALKS-8700","ALKS8700","Alks 8700","BIIB-098","BIIB098","Diroximel fumarate","RDC-5108","RDC5108"],"crossReferences":{"DailyMed":["diroximel%20fumarate"],"drugbank":["DB14783"]},"linkedTargets":{"rows":["ENSG00000079999"],"count":1},"linkedDiseases":{"rows":["MONDO_0005301","EFO_0003929"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for multiple sclerosis and has 1 investigational indication."}
{"id":"CHEMBL3990031","drugType":"Antibody","blackBoxWarning":false,"name":"ROSMANTUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OMP-131R10","Rosmantuzumab"],"linkedTargets":{"rows":["ENSG00000205213","ENSG00000146374"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4072833","canonicalSmiles":"C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1","inchiKey":"QUIWHXQETADMGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVOBRUTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evobrutinib","M-2951","Msc-2364447c","Msc2364447c"],"crossReferences":{"drugbank":["DB15170"]},"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000685","MONDO_0005301","EFO_0003929"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL420311","canonicalSmiles":"NC(=O)C1CCCc2c1[nH]c1ccc(Cl)cc21","inchiKey":"FUZYTVDVLBBXDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL420311","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124391161"],"drugbank":["DB13978"],"chEBI":["90369"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4206119","canonicalSmiles":"CCOC(=O)N1CCN(C(=O)[C@H](Cc2cccc(/C(N)=N/O)c2)NS(=O)(=O)c2c(C(C)C)cc(C(C)C)cc2C(C)C)CC1","inchiKey":"HUASEDVYRABWCV-NDEPHWFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UPAMOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mesupron","Upamostat","WX-671","Wx-671"],"crossReferences":{"drugbank":["DB13052"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL428690","canonicalSmiles":"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1","inchiKey":"BIIVYFLTOXDAOV-YVEFUNNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVOCIDIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alvocidib","Alvocidib freebase","Flavopiridol","HL 275","HL-275","HMR 1275","HMR-1275","L 86 8275","L-868275","L86-8275","MDL 107,826A","MDL-107826A","NSC-649890"],"crossReferences":{"Wikipedia":["Alvocidib"],"drugbank":["DB03496"]},"childChemblIds":["CHEMBL2105698"],"linkedTargets":{"rows":["ENSG00000123374","ENSG00000134058","ENSG00000135446","ENSG00000136807","ENSG00000105810","ENSG00000170312"],"count":6},"linkedDiseases":{"rows":["MONDO_0000956","MONDO_0007254","EFO_1001469","MONDO_0003541","EFO_0000565","EFO_1000044","EFO_0000389","EFO_0000198","EFO_0000616","EFO_0009441","MONDO_0019465","EFO_0001642","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0007576","MONDO_0008315","MONDO_0002691","EFO_0006861","EFO_0000095","MONDO_0001023","MONDO_0011962","EFO_0000191","EFO_0000574","MONDO_0002367","EFO_0001378","MONDO_0018906","EFO_1000550","EFO_0000691"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 26 investigational indications."}
{"id":"CHEMBL4297233","drugType":"Antibody","blackBoxWarning":false,"name":"OMBURTAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omburtamab"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297261","canonicalSmiles":"Cc1[nH]c2ccc(F)cc2c1-c1nc2c3cccnc3c3ncccc3c2[nH]1","inchiKey":"NIRXBXIPHUTNNI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APTO-253","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apto-253","LOR-253","LOR-253(FORMER CODE)","LT-253(FORMER CODE)","Lt-253"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297268","canonicalSmiles":"COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C","inchiKey":"AHXICHPPXIGCBN-GPWPDEGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-275183","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms 275183","Bms-275183"],"crossReferences":{"drugbank":["DB12144"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297417","canonicalSmiles":"CN1CC[C@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@H]12","inchiKey":"PBHFNBQPZCRWQP-AZUAARDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENSERINE, (+)-","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANVS-401","ANVS401","Phenserine, (+)-","Posiphen","R-phenserine"],"crossReferences":{"drugbank":["DB15317"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297601","canonicalSmiles":"COc1cc(F)c(C(C)C)cc1C1=C(CN2C(=O)O[C@H](c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H]2C)CC(C)(C)CC1","inchiKey":"GBHPDJQHZADVAA-SOKVYYICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROCACETRAPIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CKD-519","Ckd-519","Rocacetrapib"],"crossReferences":{"drugbank":["DB15437"]},"linkedTargets":{"rows":["ENSG00000087237"],"count":1},"linkedDiseases":{"rows":["Orphanet_309005"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297686","drugType":"Unknown","blackBoxWarning":false,"name":"ABY-035","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABY-035","Aby-035","Aby-035/afo2","Aby035","IMG-020","Izokibep"],"linkedTargets":{"rows":["ENSG00000112115"],"count":1},"linkedDiseases":{"rows":["EFO_1001231","EFO_0003898","EFO_0000676","EFO_0003778"],"count":4},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297943","drugType":"Unknown","blackBoxWarning":false,"name":"ECHINACEA, UNSPECIFIED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coneflower","Echinacea","Echinacea juice","Echinacea, unspecified"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297995","drugType":"Unknown","blackBoxWarning":false,"name":"BAZLITORAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bazlitoran","IMO-8400","Imo-8400"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL429876","canonicalSmiles":"CC(C)[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccccc2)C(=O)N1C","inchiKey":"AMLYAMJWYAIXIA-VWNVYAMZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CILENGITIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cilengitide","EMD 121974","EMD-12192","EMD-121974"],"crossReferences":{"Wikipedia":["Cilengitide"],"drugbank":["DB11890"]},"linkedTargets":{"rows":["ENSG00000082781","ENSG00000259207","ENSG00000138448"],"count":3},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0003086","EFO_0000756","MONDO_0000956","EFO_1001465","EFO_0002500","EFO_0002501","MONDO_0008315","EFO_0003060","EFO_1000026","EFO_0000565","EFO_0006861","MONDO_0021633","MONDO_0003165","EFO_0002428","EFO_0000326","EFO_0002499","EFO_0001378","EFO_0000707","EFO_0000691","EFO_0000519","EFO_1000158"],"count":23},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 20 investigational indications."}
{"id":"CHEMBL452715","canonicalSmiles":"N[C@@H](CN(O)N=O)C(=O)O","inchiKey":"MLFKVJCWGUZWNV-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALANOSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alanosine","L-alanosine","NSC-153353","NSC-529469","Sdx-102"],"crossReferences":{"Wikipedia":["Alanosine"],"drugbank":["DB05540"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL454950","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12.Cl","inchiKey":"XMEVHPAGJVLHIG-FMZCEJRJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACYCLINE HYDROCHLORIDE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1440","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Achromycin","Achromycin v","Actisite","Bristacycline","Cyclopar","Latycin","Panmycin","Retet","Robitet","Sumycin","Tetrachel","Tetracycline hydrochloride","Tetracyn","Tetramed","Topicycline"],"synonyms":["NSC-757338","Neocycline b","Tetracycline hcl","Tetracycline hydrochloride","Tetracyclini hydrochloridum","Vetquamycin 324"],"crossReferences":{"DailyMed":["tetracycline%20hydrochloride"],"PubChem":["144203906","144207714","170464838"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 7 approved and 2 investigational indications. It was withdrawn in United States."}
{"id":"CHEMBL4594610","drugType":"Antibody","blackBoxWarning":false,"name":"URABRELIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SRF-231","SRF231","Srf231","Urabrelimab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650284","canonicalSmiles":"O=C1Nc2cc3[nH]nc(-c4ccncc4)c3cc2CN1Cc1ccccc1","inchiKey":"ODIUJYZERXVGEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KO-947","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KO-947","Ko-947"],"linkedTargets":{"rows":["ENSG00000102882","ENSG00000100030"],"count":2},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650491","drugType":"Unknown","blackBoxWarning":false,"name":"CX-024414","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX-024414","Cx-024414","Elasomeran","M-1273","MRNA-1273","Moderna covid-19 vaccine rna","Mrna-1273","TAK-919","Tak-919"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL469662","canonicalSmiles":"N[C@@H](CCS)C(=O)O","inchiKey":"FFFHZYDWPBMWHY-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-HOMOCYSTEINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Homocysteine","L-Homocysteine"],"crossReferences":{"drugbank":["DB04422"],"chEBI":["17588"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL473659","canonicalSmiles":"CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C","inchiKey":"RLDVZILFNVRJTL-IWFVLDDISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINSENOSIDE RD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chikusetsusaponin fk7","Ginsenoside rd","Gypenoside viii"],"crossReferences":{"chEBI":["67988"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4804171","canonicalSmiles":"Cc1c(F)c(N)c2c(=O)cc(-c3ccc(NC(=O)[C@@H](N)CCCCCCN)c(F)c3)oc2c1F","inchiKey":"PRXJGLUMVDSFAU-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFP-464 FREE SALT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4802131"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL555205","canonicalSmiles":"COc1ccc2sc3c(c2c1)NC[C@@H](CN)NC3=O","inchiKey":"TXYKBKYDFZQOCB-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL555205","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07431"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL563196","canonicalSmiles":"O=C(c1ccncc1)c1ccc(F)cc1","inchiKey":"WTRWBYGUMQEFFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL563196","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06917"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL589583","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1","inchiKey":"WOUOLAUOZXOLJQ-MBSDFSHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELAPRIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Delapril"],"crossReferences":{"drugbank":["DB13312"]},"childChemblIds":["CHEMBL2106126"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL593335","canonicalSmiles":"CC(=O)NN1C(=O)N[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O","inchiKey":"MAHIOGAAEAWGLR-UTAYWCBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593335","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03835"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL64","canonicalSmiles":"NNC(=O)c1ccncc1","inchiKey":"QRXWMOHMRWLFEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ISONIAZID","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dow-isoniazid","Hyzyd","Isoniazid","Laniazid","Nicotibine","Nydrazid","Rimifon","Stanozide"],"synonyms":["Armazid","Armazide","Atcotibine","Cedin","Cotinazin","Dianicotyl","Eralon","Ertuban","Hidrasonil","Hydrazid","Ipcazide","Iscotin","Isidrina","Isobicina","Isoniazid","Isoniazidum","Isonicotan","Isonicotinylhydrazine","Mybasan","NSC-9659","Neumandin","Teebaconin","Tisiodrazida"],"crossReferences":{"DailyMed":["isoniazid"],"PubChem":["11112128","121269825","124881930","124881932","124881933","144207189","144208565","144210513","170466877","17389848","26746988","26751504","49718175","855769"],"TG-GATEs":["2"],"Wikipedia":["Isoniazid"],"drugbank":["DB00951"],"chEBI":["6030"]},"childChemblIds":["CHEMBL1090644","CHEMBL1091433"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 4 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL6466","canonicalSmiles":"O=c1ccc2ccccc2o1","inchiKey":"ZYGHJZDHTFUPRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COUMARIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lodema"],"synonyms":["1,2-benzopyrone","Cis-o-coumarinic acid lactone","Coumarin","Coumarin (prohibited)","Coumarinic lactone","Coumarinum","Cumarin","NSC-8774","Nci-c07103","O-hydroxycinnamic acid lactone","Tonka bean camphor"],"crossReferences":{"PubChem":["11533015","144204692","144209625","144210377","170465665","17389959","26753034","26753035","56422867","74390"],"TG-GATEs":["27"],"Wikipedia":["Coumarin"],"drugbank":["DB04665"],"chEBI":["28794"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL667","canonicalSmiles":"CC(=O)OCC[N+](C)(C)C","inchiKey":"OIPILFWXSMYKGL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLCHOLINE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acetylcholine"],"crossReferences":{"PubChem":["124883320","26756572"],"Wikipedia":["Acetylcholine"],"drugbank":["DB03128"],"chEBI":["15355"]},"childChemblIds":["CHEMBL1184","CHEMBL1736587","CHEMBL1427664","CHEMBL60457"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["Orphanet_232","EFO_0001645","EFO_0000556","EFO_1001461","EFO_0001073","EFO_0000537","HP_0000616","MP_0001845","EFO_0004517","MONDO_0005129","EFO_0000764","EFO_0004272","EFO_0000612","EFO_0000516","MONDO_0005148"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL71263","canonicalSmiles":"Cc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C","inchiKey":"XGOYIMQSIKSOBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VADIMEZAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-1404","ASA-404","ASA404","DMXAA","NSC-640488","Vadimezan"],"crossReferences":{"PubChem":["174006683","29217541"],"drugbank":["DB06235"],"chEBI":["75934"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL77517","canonicalSmiles":"NS(=O)(=O)c1ccc(S(=O)(=O)Nc2cccc3c(Cl)c[nH]c23)cc1","inchiKey":"SETFNECMODOHTO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDISULAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7070","E7070","Indisulam"],"crossReferences":{"drugbank":["DB06370"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL781","canonicalSmiles":"OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21","inchiKey":"ZPXSCAKFGYXMGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAZINDOL","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mazanor","Sanorex","Teronac"],"synonyms":["42-548","AN-448","Magrilon","Mazildene","Mazindol","Mazindol civ","SAH-42548","Terenac"],"crossReferences":{"Wikipedia":["Mazindol"],"drugbank":["DB00579"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0003888","EFO_0002610","MONDO_0016158","EFO_0001073"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for obesity and has 2 investigational indications."}
{"id":"CHEMBL822","canonicalSmiles":"CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12","inchiKey":"DOMXUEMWDBAQBQ-WEVVVXLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERBINAFINE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lamisil","Lamisil at"],"synonyms":["SF 86-327","SF-86-327","TDT-067","Terbinafine","Terbinafine hydrochloride"],"crossReferences":{"DailyMed":["terbinafine%20hydrochloride"],"PubChem":["144205144","170465174","26754460","29215261"],"TG-GATEs":["123"],"Wikipedia":["Terbinafine"],"drugbank":["DB00857"],"chEBI":["9448"]},"childChemblIds":["CHEMBL1200832"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for tinea and has 3 investigational indications."}
{"id":"CHEMBL86754","canonicalSmiles":"Oc1c(I)cc(I)c2cccnc12","inchiKey":"UXZFQZANDVDGMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOQUINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ioquin","Quinadome","Yodoxin"],"synonyms":["Diiodohydroxyquin","Diiodohydroxyquinoline","Diodoquin","Enterodiamoebine","Iodoquinol","Lanodoxin","NSC-8704","SS-578","Searlequin","Zoaquin"],"crossReferences":{"PubChem":["104171357","144204374","170465640","26746925","855609"],"Wikipedia":["Diiodohydroxyquinoline"],"drugbank":["DB09115"],"chEBI":["5950"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL96862","canonicalSmiles":"O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3cncnc32)[C@H](O)[C@@H]1O","inchiKey":"MCWDCZIDTUQRHK-FDDDBJFASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL96862","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03726"],"chEBI":["45262"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
